# Aflibercept With and Without Micropulse Laser in Diabetic Macular Edema

> **NCT03866746** · PHASE4 · COMPLETED · sponsor: **Al Hadi Hospital** · enrollment: 51 (actual)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **DRUG:** Aflibercept Injection
- **OTHER:** micropulsed yellow laser

## Key facts

- **NCT ID:** NCT03866746
- **Lead sponsor:** Al Hadi Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-08
- **Primary completion:** 2017-06-21
- **Final completion:** 2018-12-28
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2019-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03866746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03866746, "Aflibercept With and Without Micropulse Laser in Diabetic Macular Edema". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03866746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*